Tissue Analytics, Inc., the leading mobile imaging and artificial intelligence platform for wound, skin, and ostomy management, today announced the appointment of Rafael Mazuz to the company’s Board of Directors.
| BALTIMORE, /PRNewswire/ -- Tissue Analytics, Inc., the leading mobile imaging and artificial intelligence platform for wound, skin, and ostomy management, today announced the appointment of Rafael Mazuz to the company’s Board of Directors. Mazuz is Managing Director of Diligence Wound Care Global, the world’s top wound care and regenerative medicine advisory firm, empowering executives, investors, and specialists to be confident in their wound care business decisions.
Mazuz is an accomplished wound care executive, having directed and mentored wound care centers for the largest provider of wound care management services. He regularly speaks at international wound care conferences, contributes to reputable healthcare and medtech publications, and serves on the editorial advisory board of Today’s Wound Clinic. Mazuz’s clients at Diligence Wound Care Global include major wound care firms and many preeminent institutional investors. “For years, I have seen industry management struggle with challenges related to strategic direction, sluggish execution, product commoditization, geographic expansion, reimbursement pressures, as well as slow, expensive, and under-impressive clinical outcomes data,” explains Mazuz. “The more opportunities I had to assess and later work with Tissue Analytics to address such client needs, I concluded that all serious wound and skin care players--regardless of size--stand only to gain from being part of this best-in-class ecosystem.” “We are thrilled to have Rafael join our board,” added Tissue Analytics Co-founder and CEO Kevin Keenahan. “Not only does he bring valuable wound care expertise to ensure we best serve our clients and capitalize on unmet needs, but his decision to align with our vision and solution is a huge vote of confidence for both our internal and external stakeholders.” Earlier this year, Tissue Analytics celebrated a $5M Series A fundraising round, and has continued to add top healthcare systems and multiple key medtech clients to its cutting edge platform. The company has recently established industry leading partnerships and deployed integrations with the industry’s largest Electronic Medical Record (EMR) vendors, as well as launching a first-of-its-kind 3D measurement functionality, making external hardware attachments for wound measurements virtually obsolete. About Tissue Analytics Tissue Analytics, Inc. develops AI-powered software solutions that serve clinicians, industry, payer, and research stakeholders in various therapy areas. The platform uses best-in-class machine learning and computer vision to optimize documentation workflows and improve the quality of electronic medical records (EMR) data. Tissue Analytics, Inc. was incorporated in 2014 and is based in Baltimore, Maryland with a satellite office in Kansas City, Missouri. For more information, visit tissue-analytics.com or connect on LinkedIn, Twitter or Facebook. Media Contact:
SOURCE Tissue Analytics, Inc. |
View original content to download multimedia:
